Both in Pharmaceuticals
Aclaris Therapeutics vs Bicara Therapeutics
Over the past year ACRS returned +47.5% and BCAX returned −42.7%; their daily moves had a correlation of 0.19.
ACRS +47.5% BCAX −42.7%Growth of $1, one year, split-adjusted
| Metric | ACRS | BCAX |
|---|---|---|
| Price | $3.78 | $9.16 |
| Market cap | $585.1M | $606.1M |
| Today | −0.66% | +15.51% |
| 1 month | −11.6% | −47.0% |
| 6 months | −20.5% | −60.4% |
| Year to date | +25.4% | −45.6% |
| 1 year | +49.8% | −43.6% |
| Revenue growth (YoY) | −8.3% | — |
| Gross margin | 86.6% | — |
| Net margin | −1320.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 71.2× | — |
| Net cash | $91.6M | $497.3M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 135.8% |
| Short % of float | 12.4% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).